ADVANCED CELL DIAGNOSTICS INC.

Company Snapshot

Founded: 2006

Entity Type: Private

Region: U.S.

Headquarter: California, U.S.

Key Geographics: U.S., China

Company Overview

Advanced Cell Diagnostics is a leader in the field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. The company’s products and pharma assay services are based on its proprietary RNAscope technology. It has developed the first multiplex fluorescent and chromogenic in situ hybridization platform, which is capable of identifying and quantifying distinct molecules of RNA in situ. The company has two primary product lines, namely, RNAscope and BaseScope, along with assay reagent kits and other off-the-shelf products and pharma assay services. At present, the company operates as a subsidiary of Bio-Techne Corp.

ADVANCED CELL DIAGNOSTICS INC. In Reports

Next-Generation Cancer Diagnostics: Technologies and Global Markets

BCC Research Market Report says next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a CAGR of 11.5%.

Global Spatial Genomics and Transcriptomics Market

BCC Research Market Analysis Report for Spatial Genomics & Transcriptomics is estimated to increase from $1.5 bln in 2022 to reach $2.5 bln by 2027 at CAGR of 10.8%.

Global Microarray Market

BCC Research Market Report for Microarray. A comprehensive overview of the global markets for microarray technologies.

View All Reports

ADVANCED CELL DIAGNOSTICS INC. In News

The biotech bi-weekly: optimizing qPCR and spatial biology research, making cell cultivation more sustainable and ushering in a new era of drug discovery - BioTechniques

BioTechniques - Feb 26, 2025

Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu - Yahoo Finance

Yahoo Finance - Feb 24, 2025

Global Multiplex Assay Market to Hit USD 8.84 Billion by - GlobeNewswire

GlobeNewswire - May 28, 2025

BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS - PR Newswire

PR Newswire - Jan 29, 2024

Read All News

Company's Business Segments

Products : The company generates revenue from various products such as RNAscope or BaseScope, Target Probes, Controls, Manual assays, Automated Assays, Accessories, Software.
Services : The company generates revenue from services such as Biomarker Assay Development, Cell and Gene Therapy Services, Clinical Assay Development, Tissue Bank and Sample Procurement, Image Analysis.

Applications/End User Industries

Healthcare

Pharmaceuticals

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.